ReviewTherapeutic advances in drug safety2022

Safety of dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.

Katharina Doni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.